None listed
Conditions
Brief summary
Sexual problems are highly prevalent and are frequently associated with personal distress and impaired quality of life. Approximately 42% of women complained of one or more sexual problems, compared with about 30% of men.Sexual dysfunction often cause problems in sexual life like pain, decreased sexual desire or libido, lack of responsiveness to sexual stimulation, and diminished sexual pleasure or satisfaction. The aim of this randomised cross-over repeated measures study is to determine whether there is a measurable difference in outcomes for pain and sexual function in patients receiving pelvic floor muscle training compared to a control intervention.
Interventions
Assessment of pelvic floor muscles function through PERFECT scheme (power, endurance, repetition, fast contraction, co-contraction and timing of pelvic floor muscles). Participants will undergo assessment immediately prior to intervention and at four week post intervention. Pelvic floor muscle training – these are exercises for strength and endurance of pelvic floor muscles. The number of pelvic floor exercises undertaken as part of each session is 8-10 times with duration of each session for 30 minutes. The sessions are carried out on an individual basis. There will be 4 appointments with a physiotherapist over 4 weeks, supplemented by a daily program of 3 exercise sessions. The duration of each session with physiotherapist is 45 minutes. The duration of daily home program sessions is 8-10 repetitions 3x30 minute sessions daily for 4 weeks. Each session involve voluntary contraction of urethral, vaginal and anal opening in supine position, side-lying position, sitting and in standing position. Duration of each voluntary contraction of each opening is 6-8 seconds under supervision by physiotherapists.There are not applicable strategies for monitor adherence to the intervention.TENS is not administered to the intervention group. The duration period between treatments is one week.
Sponsors
Study design
Eligibility
Inclusion criteria
vaginismus or dyspareunia or vulvodynia or erectile dysfunction or premature ejaculation or hysterectomia
Exclusion criteria
hyperthyroidism, antipsychotics, antidepressants, sedatives, narcotics, chemotherapy